Westchester Capital Management (New York)’s NxStage Medical Inc. NXTM Stock Holding History

Westchester Capital Management (New York)’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,250,824	Closed	-$64.4M	–	137
2018 Q4	$64.4M	Buy	2,250,824 +1,103,411	+96%	+$31.3M	2.84%	10
2018 Q3	$32M	Buy	1,147,413 +619,919	+118%	+$17.4M	1.22%	22
2018 Q2	$14.7M	Buy	+527,494	New	+$14.1M	0.59%	29

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Westchester Capital Management (New York)'s NXTM Position: Q1 2019 in Review

Westchester Capital Management (New York) sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 2,250,824 shares — an estimated $64.4M sold.

Westchester Capital Management (New York) first reported a position in NXTM in Q2 2018 and held it in 3 quarters. The position peaked at $64.4M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Westchester Capital Management (New York) reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Westchester Capital Management (New York) sold 2,250,824 NxStage Medical Inc. shares in Q1 2019, an estimated $64.4M.
Westchester Capital Management (New York) first reported a position in NxStage Medical Inc. in Q2 2018 and held it in 3 quarters.
Westchester Capital Management (New York)'s NxStage Medical Inc. position peaked at $64.4M in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2019, filed 15 May 2019.